Phosphorylated c-Abl immunoreactivity in G93A mice was significantly increased compared to control mice with both antibodies (P<0.01), which indicated that c-Abl was activated at an early stage of disease in this mouse model of ALS (Fig. S1). The gene discussed is ABL1; the disease is amyotrophic lateral sclerosis.